We know when it comes to cancer research, there’s nothing more important than providing comprehensive and innovative preclinical services. We’re excited to introduce our expanded oncology CRO services at the American Association for Cancer Research’s annual meeting in Orlando from April 14–19. Visit our booth 569 and learn how we can assist with your current and future research needs with our wide range of capabilities.
Mouse models
- Syngeneic Tumor Models
- Orthotopic, Metastasis/Disseminated Xenograft Models
- Humanized Mouse Models
- Patient-derived Xenograft Models (PDX)
- Cell Line-derived Xenograft Models (CDX)
Imaging
- IVIS Optical Live Animal Imaging
- Fluoroscopy Imaging System
- Radiology
- Ultrasound
In Vitro Assays
- Expansion and Activation of CAR-T Cells (Proliferation, Activation, Cytolytic Activity & Cytokine Production of CAR-T Cells)
- Flexibility to Build Out T-cell Production Capabilities
- Flow Cytometry-Based Assays to Support Immuno-oncology Drug Development
- Cytotoxicity and Immunotoxicity Assays
- PK/PD and Efficacy Studies
- Flow and PCR-based Biodistribution Assays
- Cellular Activation and Stimulation Assays
- Human Whole Blood Stimulation Assays
Meet the Noble Attendee
See Us at Booth 569
Srujana Cherukuri, Ph.D
Chief Executive Officer
Stephen K. Horrigan, Ph.D.
Chief Scientific Officer
Edwin Gershom, Ph.D.
Business Development Manager
Visit Us at Booth 569
AACR ANNUAL MEETING 2023
April 14–19, 2023 | Orange County Convention Center | Orlando, Florida